Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-05-23 | New | $3,999,994 | $3,999,994 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Sourav Banerjee | Director |
| Christopher Hulme | Director |
| Curtis Thorne | Director, Executive |